...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith MD&A and Financials are up

The April 30 year-end is available on SEDAR now also. There seemed to be something wrong with SEDAR earlier as I tried early this morning and couldn't get more than just Zenith.

Share
New Message
Please login to post a reply